About

Adam Feinstein has served on AirSculpt's Board since June 2021 and was its lead independent director from March 2023 until November 2025. He previously served as non-executive chairman of the Board from September 2021 to January 2023 and as non-executive chairman of the board of managers of Elite Body Sculpture, the Company's predecessor, from October 2018 until the initial public offering.

He founded Vesey Street Capital Partners, L.L.C., AirSculpt's private equity sponsor, in 2014 and serves as its Managing Partner. Before founding VSCP, he was Senior Vice President of Corporate Development, Strategic Planning and the Office of the Chief Executive Officer at LabCorp from 2012 to 2014, and earlier spent 14 years as a Managing Director in equity research at Barclays Capital/Lehman Brothers.

Mr. Feinstein is a CFA charterholder and holds a B.S. in Business from the Smith School at the University of Maryland; he also completed the Nashville Healthcare Council Fellows program.

Roles

Airsculpt Technologies, Inc.
Director · Current role
2021–present
Vesey Street Capital Partners, L.L.C.
Founder & Managing Partner
2014-present
LabCorp
SVP, Corporate Development, Strategic Planning & Office of the CEO
2012-2014
Barclays Capital / Lehman Brothers
Managing Director, Equity Research · 14-year tenure.

External Roles

PathGroup
Director
2016-present
Safecor Health
Director
2021-present
ComplexCare Solutions
Director
2024-present
Inceptua Group
Director
2024-present
Orthopedic Solutions Management
Director
2025-present
Shemassian Academic Consulting
Director
2025-present
Surgery Partners, Inc. (Nasdaq: SGRY)
Director
2015-2019
QualityMetric
Chairman
2020-2023

Also at Airsculpt Technologies, Inc.

Related

See how VectorShift works for your firm

Request Demo